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Abstract 
Background: Neisseria gonorrhoeae is a bacterium responsible for one of the classic sexually transmitted infection 
(STI) gonorrhea. Antibiotic resistant strains are emerging at alarming rate. Multiple sexual partners, unsafe sex and 
substance use habits are the main host related risk factors for acquiring the infection. Thus, this study aimed at deter-
mining the magnitude, its determinants and antimicrobial resistance profile of N. gonorrhoeae in a place where there 
is risk related cultural practices and relatively high HIV prevalence.
Methods: A cross-sectional study was conducted on 186 STI suspected patients seen in Gambella hospital from 
March to July 2015. Data on socio-demographic characteristics and associated risk factors was collected using pre-
designed questionnaire. Urethral or endo-cervical swabs were collected aseptically by trained nurses. Then, samples 
were transported to laboratory and processed within 15 min following standard microbiological culture techniques. 
Antimicrobial susceptibility test was performed by using Kirby-Bauer disk diffusion method. Data entry, transforming 
and analysis was done using SPSS version 20.
Results: In this study 11.3 % of the STI suspected patients were confirmed to have N. gonorrhoeae. The rate of 
infection in males was four times higher than in females accounting 16.0 and 5.0 % respectively (p = 0.049). It was 
also higher (18.9 %) in 20–24 years age group (p = 0.439). Alcohol intake (p = 0.013), less frequent condom use 
(p = 0.031), and multiple sex partners (p = 0.024) were associated with increased odds of infection. All N. gonorrhoeae 
isolates were susceptible to ceftriaxone and cefoxitin but all were resistant to penicillin and tetracycline. Alarmingly, 
28.6 % of the isolates were resistant to ciprofloxacin.
Conclusions: The proportion of urogenital symptoms attributable to N. gonorrhoeae was high (11 %), with highest 
prevalence among males and young adults. Hence, prevention efforts should consider behavioral risk reduction. Cef-
triaxone and cefoxitin can be considered as excellent first-line treatment options. However, alarming rate of resistance 
to ciprofloxacin challenges the current use of this antibiotic in the syndromic management package of gonococcal 
infections. Thus, laboratory based diagnosis and treatment system is need.
© 2016 The Author(s). This article is distributed under the terms of the Creative Commons Attribution 4.0 International License 
(http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, 
provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, 
and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/
publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Background
Neisseria gonorrhoeae is a gram negative coffee-bean 
shaped intracellular diplococcus bacterium responsi-
ble for gonorrhea which is one of the classical sexually 
transmitted infections (STIs) [1]. Gonorrhea can also be 
transmitted from mother to child during delivery and 
cause infection of the eye of the newborn [1–3]. Genital 
tract gonorrhea gives rise to well recognized complica-
tions such as pelvic inflammatory disease with possible 
sequelae including infertility, ectopic pregnancy, fetal 
wastage, neonatal ophthalmia and disseminated gono-
coccal (GC) infections. People with gonorrhea infection 
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have increased risk of HIV acquisition and transmission 
[2, 4, 5].
Antibiotic resistant N. gonorrhoeae is emerging at an 
alarming rate in many parts of the world, especially in 
developing countries. As a result, inexpensive treatment 
regimens of gonorrhea in those countries have been ren-
dered ineffective while efficacious ones are often unaf-
fordable [3, 6, 7]. After years of easy susceptibility of 
N. gonorrhoeae to penicillin and other antibiotics, there 
is a worrying trend of antimicrobial resistance to the 
commonly prescribed antibiotics such as quinolones and 
cephalosporins. Although, the Center for Disease Con-
trol (CDC) recommends a combination therapy such as, 
ceftriaxone plus either azithromycin or doxycycline as 
first-line treatment for gonorrhea, it also noted that as a 
result of high drug resistant ability of gonococci cephalo-
sporin resistance, especially ceftriaxone resistance, would 
greatly limit treatment options and cripple gonorrhea 
control efforts [8].
In 2008 the World Health Organization (WHO) esti-
mated that about 106.1 million new cases of GC infections 
occurred globally and about 21.1 million in Africa, making 
it the second most common sexually transmitted bacterial 
infection worldwide [5]. Moreover, the global prevalence 
of N. gonorrhoeae in adults between the ages of 15 and 
49 years was estimated to be 36.4 million in 2008. Mean-
while in Africa the prevalence in these age groups was esti-
mated to be 8.2 million [5]. Some of the recent studies in 
Africa showed that the prevalence of the disease in STI sus-
pected patients ranges from 2.7 to 8.2 % in various target 
groups [6, 7]. Up to 17.7 % gonorrhea prevalence was also 
detected among anti-retroviral treatment (ART) attendees 
[9]. As indicated, in sexually transmitted diseases treatment 
guideline, multiple sexual partners, sexually active age, 
unsafe sex practice, lower socio-economic status, urban 
residence and substance use are among the list of host 
related risk factors for acquiring the infection [10].
The few available reports on prevalence of N. gonor-
rhoeae in Ethiopia showed significant variation in its 
distribution among the regions. Due to unavailability of 
culture-facility in health institutions in the country, the 
treatment of gonorrhea is almost empirical and antibi-
otics are generally given without considering sensitiv-
ity report. Recently in any health facilities the STI case 
are routinely managed by syndromic approach [11, 12] 
where patients suspected of N. gonorrhoeae infection are 
treated empirically by giving antibiotics recommended in 
the package. On the other hand, Gambella is one of the 
regions where polygamy and levirate marriages are very 
common [13] and male circumcision is rare [14]. Such 
practices are expected to be risks for STI and HIV acqui-
sition. This might explain why the prevalence of HIV 
in the region ranks the highest (6.5  %) in Ethiopia [15]. 
Despite this risk related cultural practices and relative 
high HIV prevalence in the region, there is no adequate 
information about the magnitude, its determinants and 
antimicrobial resistance status of N. gonorrhoeae.
Methods
Study area and design
A cross sectional study was conducted from March to 
July 2015 on STI suspected patients attending the outpa-
tient department (OPD) of Gambella hospital, Gambella 
regional state, Ethiopia. The total annual patient flow of 
the hospital in 2014 was 244,656 of which 580 were STI 
cases. Syndromic approach is often used to manage STI 
cases in Gambella hospital and in all other health care 
facilities in the region. In this approach, patients sus-
pected of N. gonorrhoeae infection, are managed by giv-
ing antibiotics such as ciprofloxacin 500  mg tablet by 
mouth stat (commonly), or spectinomycin 2 g intramus-
cular (IM) stat (occasionally) or ceftriaxone 250 mg IM as 
a sing dose (for recurrent infection) in combination with 
other antibiotics whenever required [11, 12].
The minimum representative sample size was deter-
mined using single population proportion formula by 
taking 8.2  % prevalence rate of N. gonorrhoeae docu-
mented in the same country [7] is with margin of error 
4.1 at 5 % level of significance. All STI suspected patients 
whose age  ≥15  years and had no history of antibiotic 
treatment in the preceding 2 weeks were included in the 
study. Written consent was obtained from study partici-
pant patients prior to data collection. Then, information 
on sociodemographic and other variables of interest was 
collected by trained data collectors using pre-designed 
questioners.
Sample collection, and processing
Urethral or endo-cervical swabs (two swabs from each 
individual) were collected aseptically following stand-
ard procedures [16] by trained nurses. Urethral swabs 
from men were collected by gently massaging the ure-
thra down wards from above using sterile cotton wool 
swabs. For those who had no noticeable pus the swabs 
were inserted approximately 2 cm into their urethra and 
rotated gently before withdrawing. In females, the cer-
vical swabs were collected from the endocervical canal 
using well disinfected vaginal speculum. Then, the swabs 
were immediately put in Amies transport media (Oxoid 
limited, Basingstoke, RG24 8PW, UK), transported to 
the Gambella Regional Laboratory and processed within 
15 min of collection [16].
Bacteria identification
Of these two swabs, one was used for Gram stain and 
the other was inoculated directly into the modified 
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Thayer Martin medium (MTM) and incubated at 37  °C 
for 24–48 h in a moist atmosphere enriched with 5–10 % 
CO2 (i.e. by putting soaked gauze inside the candle 
jar). Positive culture was identified by its characteristic 
appearance on the media (i.e. small raised, grey shiny 
colonies after overnight incubation on MTM). Suspected 
single colony from MTM was taken and subcultured 
on a GC-chocolate agar with 1 % Vitox supplement and 
incubated for overnight. Confirmation of N. gonorrhoeae 
isolates was done by Gram-stain, Biochemical tests 
(including oxidase, superoxol & carbohydrate utilization 
tests) [16] and using Analytical Profile Index for Identi-
fication of Neisseria and Hemophilia (API NH) identifi-
cation kit strips (BioMerieux, France). Isolates that are 
oxidase positive, superoxol positive and fermenting only 
glucose were considered as N. gonorrhoeae [17, 18].
Antimicrobial susceptibility testing
Antimicrobial susceptibility testing was performed for all 
isolates according to the criteria of Clinical and Labora-
tory Standard Institute (CLSI) by the Kirby-Bauer disk 
diffusion method [19]. Bacterial suspensions with turbid-
ity standard equivalent to McFarland 0.5 were swabbed 
evenly on GC-chocolate agar with 1 % Vitox supplement. 
A set of six antibiotic discs (Oxoid Ltd., Basingstoke, 
Hampshire, England) with the following concentrations: 
tetracycline 30  µg, penicillin 10 Iu, ciprofloxacin 5  µg, 
spectinomycin 100  µg, cefoxitin 30  µg and ceftriaxone 
30 µg were placed on the surface of the plate. Then, the 
plates were incubated at 37  °C in candle jar, generating 
5–10 % CO2, for 20–24 h. Zone of inhibition diameters in 
mm were measured and interpreted as sensitive, interme-
diate and resistant according to the principles established 
by CLSI [19]. In order to monitor quality (potency) of 
disks, a standard strain of N. gonorrhoeae American Type 
Culture Collection (ATCC) 49226 was tested at regular 
interval. The tested antibiotics were selected based on the 
national list of medicines by Food, Medicine and Health-
Care Administration and Control Authority (FMHACA) 
Ethiopia in 2010 to treat infections, Syndromic manage-
ment package for the management of sexually transmit-
ted infections, Federal democratic repuplic of Ethiopia 
[11, 12] and prescription frequencies.
Data analysis
Data entry, transforming and analysis was done using 
SPSS version 20. Frequency of variables was determined 
and descriptive findings were presented using tables 
and graphs. Crude odds ratio (COR) and adjusted odds 
ratio (AOR) with 95 % confidence interval (CI) were cal-
culated. p value was calculated to identify statistical sig-
nificance. Binary logistic regression was used to assess 
the associations between dependent (N. gonorrhoeae 
infection) and independent (demographic and behavio-
ral) variables. Variables with p value less than 0.25 were 
taken as candidates to enter multiple logistic regression 
model and variables with p  <  0.05 were reported with 
95  % CI and AOR as determinant factor for N. gonor-
rhoeae infection.
Results
Socio‑demographic characteristics of the study participant 
patients
During the study period a total of 189 STI suspected 
patients were seen in Gambella hospital outpatient 
department (OPD) of which 186 of them gave their con-
sent to participate. The sex and age profile of participants 
showed that 106 (57 %) were males and their age ranged 
from 15 to 65 years the mean age being 28.9 ± 8.3 years. 
Out of 186 participants whose urethral or endocervical 
swabs were investigated, 21 (11.3  %) were confirmed to 
have gonococcal (GC) infection. The highest frequency of 
GC infection occurred among 20–20 year-olds (19 %) as 
compared to 15–19 year-olds in which no infection was 
seen (0 %) and older age groups (Fig. 1). However, the dif-
ference was not statistically significant (Table 1).
The prevalence of GC infection in males was much 
higher than females accounting for 16 and 5  % respec-
tively i.e. the odds of having infection in men was four-
times higher than women (p = 0.049, AOR = 4.24, (95 % 
CI 1.01, 17.82). The prevalence of infection was higher 
among rural residents (17.3 vs. 9.0  % urban), married 
person (12.5 vs. 9.5  % unmarried), employees (15 vs. 
11.1 % merchants), higher educated (13.3 vs. 10.5 % illit-
erate and 8.1 % primary school) and those with medium 
Fig. 1 Proportion of N. gonorrhoeae by age group and sex of STI 
suspected patients (n = 186) in Gambella hospital, Ethiopia, (March–
July 2015)
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income (22.2 % USD 25–50 vs. 5.3 % USD <25 and 11.4 % 
USD  >50). However, the residential set up and any of 
those tested sociodemographic variables showed no sta-
tistical association with the GC infection (Table 1).
Substance use and sexual risk behavior of participant 
patients
The assessment on sexual risk behavior and substance 
use showed that the rate of GC infection among those 
who ever use shisha and chew Khat (Catha edulis) was 
27.3 %, (p = 0.100) and 17.2 %, (p = 0.276) respectively. 
The rate of infection among cigarette smokers was 38.1 % 
[(p  =  0.015), AOR (95  % CI)  =  4.84 (1.35, 17.34)] and 
those who often drink alcohol was 19.3  % [(p =  0.013), 
AOR (95  % CI)  =  5.53(1.44, 21.24)]. The verified data 
indicates that cigarette smoking and frequent alcohol 
drinking habit showed statistically significant association 
with GC infection (Table 2).
Out of 14 respondents who had multiple sexual part-
ner, 42.9  % were positive for GC infection (p  =  0.024) 
with an AOR = 6.12 and 95 % CI = 1.27, 29.86. The rate 
of infection among these positive males with multiple 
sexual partners was fivefold greater than women with 
the same category i.e. 37.7  % vis-a-vis 7.1  % (data not 
Table 1 Distribution of  N. gonorrhoeae infection in  relation to  socio-demographic characteristics of  STI suspected 
patients (n = 186) seen in Gambella hospital, Ethiopia (March–July 2015)
S & A secondary and above, AMI average monthly income, 1* indicator








Male (106) 17 (16.0) 89 (84.0) 3.63 (1.17, 11.25) 0.026 4.24 (1.01, 17.82) 0.049
Female (80) 4 (5.0) 76 (95.0) 1* 1*
Age
15–19 (20) 0 (0.0) 20 (100.0) 0.000 (0.000) 0.439
20–24 (37) 7 (18.9) 30 (81.1) 4.78 (0.93, 24.67)
25–29 (59 9 (15.3) 50 (84.7) 3.69 (0.76, 18.04)
30–34 (27) 3 (11.1) 24 (88.9) 2.56 (0.40, 16.44)
>35 (43) 2 (4.7) 41(95.3) 1*
Residence
Urban (134) 12 (9.0) 122 (91.0) 1* 0.112 1* 0.477
Rural (52) 9 (17.3) 43 (82.7) 2.13 (0.84, 5.40) 1.51(0.49, 4.66)
Marital status
Married (112) 14 (12.5) 98 (87.5) 1* 0.523
Unmarried (74) 7 (9.5) 67 (90.5) 0.73 (0.28, 1.91)
Educational status
Illiterate (19) 2(10.5) 17 (89.5) 0.77 (0.16, 0.67) 0.585
Primary (1–8) (62) 5 (8.1) 57 (91.9) 0.57 (0.195, 1.668)
S & A (105) 14 (13.3) 91 (86.7) 1*
Occupation
Employee (80) 12 (15.0) 68 (85.0) 1* 0.978
House wife (25) 0 (0.0) 25 (100) 0.000 (0.000)
Farmer (13) 1 (7.7) 12 (92.3) 0.47 (0.06, 0.96)
Student (39) 5 (12.8) 34 (87.2) 0.83 (0.27, 2.56)
Merchant (18) 2 (11.1) 16 (88.9) 0.708 (0.14, 3.48)
Others (11) 1 (9.1) 10 (90.9) 0.57 (0.07, 4.84)
AMI (USD)
No income (15) 2 (13.3) 13 (86.7) 1.33 (0.26, 6.68) 0.225 10.82 (1.31, 89.63) 0.173
<25 (38) 2 (5.3) 36 (94.7) 0.48 (0.10, 2.27) 2.89 (0.42, 19.86)
25–50 (27) 6 (22.2) 21 (77.8) 2.47 (0.82, 7.42) 1.78 (0.427, 7.40)
>50 (106) 11(10.4) 95 (89.6) 1* 1*
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shown). The proportion of STI due to N. gonorrhoeae was 
12.9  % among those who reported not using condoms 
compared to 5.1  % among those who reported condom 
use (p = 0.188). The odds of having GC infection among 
those who never use condom was eight times higher than 
who use regularly [AOR = 7.92 (95 % CI = 1.21, 51.90)] 
(Table 2).
Antimicrobial drug resistance pattern
Neisseria gonorrhoeae isolates were 100 % susceptible to 
ceftriaxone and cefoxitin. But, they were 100 % resistant 
to penicillin and tetracycline. Alarming rate (28.6  %) of 
resistance was also seen against ciprofloxacin. Moreover, 
intermediate resistance was seen in 4.8  % of the isolate 
for spectinomycin and 14.3 % for ciprofloxacin (Table 3).
Discussion
In this study, the prevalence of N. gonorrhoeae among 
suspected STI patients was 11.3 %, which is higher than 
5.1  % reported in Hawassa, Ethiopia [6], 8.2  % in Bahir 
Dar, Ethiopia [7], 1.2  % in Bangladesh [4] and 8.4  % in 
Tanzania [20]. This relative increased rate of gonococcal 
(GC) infections seen in our study might be due to risky 
cultural practices in the region where there is poly gamy, 
levirate marriage [13] and rare male circumcision [14] 
which purporting to show that circumcision reduced the 
risk of gonorrhea infection [21]. Such practices could be 
precipitating risk factors for STI and HIV acquisition as 
the prevalence of HIV in the region is reported to be the 
highest in Ethiopia [15]. The relative high rate of infec-
tion might also goes with the analogy that the presence 
of other sexually transmitted disease (STD) and HIV 
increases the risk of acquiring N. gonorrhoeae and vice 
versa [10]. Another factor that contributes for the higher 
infection rate might be lack of good clinical and diag-
nostic facilities in the region which intern weakens STI 
management systems (i.e. strict case identification, coun-
seling and treatment). In contrast to these, the 11.3  % 
prevalence rate obtained in present study was lower than 
17.7  % a report in Jimma, Ethiopia [9], 42  % in Bangla-
desh [22], 59 % in Uganda [23] and 80 % in Malawi [24]. 
The variation in prevalence rate in those studies may be 
due to differences in target population where ART follow 
up cases in Jimma, commercial sex workers in Bangla-
desh and patients only with urethral discharge in Malawi 
were included in their study.
In our study, the odds of GC infection in males was 
four-times higher than females of the same age group 
[(P =  0.049), AOR =  4.24, (95  % CI, 1.01, 17.82)]. This 
might be due to the aforementioned risky cultural 
Table 2 Distribution N. gonorrhoeae infection in  relation to  substance use, and  sexual risk behaviors of  STI suspected 
patients (n = 186) seen at Gambella hospital, Ethiopia (March–July 2015)
CS cigarette smoking, NS number of sexual partner, 1* indicator
Substance use and  
sexual risk behavior







Yes (11) 3 (27.3) 8 (72.7) 3.27 (0.80, 13.45) 0.100
No (175) 18 (10.3) 157 (89.7) 1*
Alcohol intake
Yes (83) 16 (19.3) 67 (80.7) 4.68 (1.64, 3.39) 0.004 5.53 (1.44, 21.24) 0.013
No (103) 5 (4.9) 98 (95.1) 1* 1*
CS
Yes (21) 8 (38.1) 13 (61.9) 7.20 (2.53, 20.50) <0.001 4.84 (1.35, 17.34) 0.015
No (165) 13 (7.9) 152 (92.1) 1* 1*
Chewing khat
Yes (29) 5 (17.2) 24 (82.8) 1.84 (0.62, 5.48) 0.276
No (157) 16 (10.2) 141 (89.8) 1*
Condom use
Yes (39) 2 (5.1) 37 (94.9) 1* 0.188 1* 0.031
No (147) 19 (12.9) 128 (87.1) 2.75 (0.61, 2.34) 7.92 (1.21, 51.90)
NSP
1–2 (172) 15 (8.7) 157 (91.3) 1* 0.001 1* 0.024
>2 (14) 6 (42.9) 8 (51.1) 7.85 (2.40, 25.64) 6.12 (1.27, 29.86)
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practices a in the region [13, 14]. By nature, males are 
more symptomatic for the infection which may also 
enhance their health care seeking behavior and more 
likely appeared in the statistics. Gonococcal infec-
tion in this study was also more frequent in 20–24 and 
25–29 years of age groups. It is documented that sexually 
active age groups are at risk of acquiring STIs [10] as they 
are much more prone to sexual promiscuity and unsafe 
sex practices.
The bivarate and multivariate analysis on substance 
use in this study revealed that unlike shisha use and 
khat chewing practices, alcohol drinking (p  =  0.013, 
AOR = 5.53, 95 % CI = 1.44–21.24) and cigarette smok-
ing (p =  0.015, AOR =  4.84, CI =  1.35–17.34) showed 
statistical significant association with GC infection. This 
is due to the fact that alcohol drink and cigarette smoking 
are cofactors as individuals are more motivated to take 
risks of unsafe sex while under the influence of alcohol.
Moreover, the logistic regression analysis on sexual 
risk behavior such as having multiple sexual partner 
(p = 0.024, AOR = 6.12, 95 % CI = 1.27, 29.86) and con-
dom use habit (p = 0.031, AOR = 7.92, 95 % CI = 1.21–
51.90) also showed statistically significant association 
with the infection. Participants with lack of condom use 
and multiple sex partners had several times the odds of 
GC infection. Association of GC infection with two pre-
dictor variables (i.e. alcohol drinking and condom use) 
was documented in similar study on ART attendees in 
Jimma, Ethiopia [9]. Statistical association of GC infec-
tion with study participants having multiple sexual part-
ners was also reported in South Africa [25] and Tanzania 
[20].
In this study all isolates were 100 % susceptible to cef-
triaxone which was analogous to 100  % susceptibility 
reported in Nepal [26], India [27], Brazil [28], Tanza-
nia [20] and Ethiopia [6]. Our finding was also compa-
rable to 99  % susceptibility towards the same antibiotic 
documented in Bangladesh [22]. Such effectiveness of 
ceftriaxone might be associated with limited use and 
prescription of the drug in the study area because of its 
high cost. In contrary to our findings, 27.8  % resistant 
isolates to ceftriaxone was reported in Bahir Dar, north 
west Ethiopia [7]. However, it is difficult to give possible 
explanation for such contrasting findings documented in 
the same country.
The N. gonorrhoeae isolates in this study was 100  % 
susceptible to cefoxitin which is higher than 82  % sus-
ceptibility reported in Hawassa, Ethiopia [6]. Similarly, 
our isolates were 95.2  % susceptible to spectinomycin 
which is also higher than 82 % susceptibility reported in 
Hawassa [6]. These two antibiotics remain effective in the 
area because the drugs are newly introduced so that not 
used widely and frequently. However, 95.2 % susceptibil-
ity to spectinomycin obtained in this study was somehow 
lower compared to each 100 % susceptibility documented 
in Bangladesh [22] and Brazil [28].
In this study, N. gonorrhoeae isolates showed alarming 
rate (28.6 %) of resistance against ciprofloxacin which is 
higher than 18 % resistance to the same drug reported in 
Ethiopia [6], 20 % in Nepal [26], 21.4 % in Brazil [28] and 
23.3  % in Uganda [23]. Such relative high rate of resist-
ance seen in this study might be due to easly availabil-
ity, indiscriminate and intensive use of this antibiotic in 
all health facilities in the country. Since ciprofloxacin is 
included in the syndromic management package, it is 
often used in combination with doxycycline or azithro-
mycin for infections concomitant with Chlamydia tra-
chomatis. It is also widely used both for other STDs and 
various bacterial infections. The alarming percentage of 
resistance against ciprofloxacin observed in our study 
challenges the current use of this drug in the syndromic 
management package of GC infections. Hence, switching 
from ciprofloxacin to ceftriaxone was optimal when the 
prevalence of gonorrhea was >3 % and the prevalence of 
ciprofloxacin resistance was >5 % as it was suggested by 
Roy K [31].
In this study, all the isolates showed 100  % resistant 
to penicillin and tetracycline. Such an extreme resist-
ance against these antibiotics is due to the fact that 
about 90.5 % of our isolates were tested as penicillinase 
producers [18]. The 100  % resistance seen in our study 
was higher than 82  % penicillin resistance reported in 
Table 3 Antimicrobial drug resistance patterns of  N. gonorrhoeae isolates from  STI suspected patients at  Gambella 
hospital, Ethiopia (March–July 2015)
S sensitive, I intermediate, R resistant, FOX cefoxitin, CRO ceftriaxone, SPT spectinomycin, CIP ciprofloxacin, P penicillin, T tetracycline
Organism Pattern Drugs tested No (%)
FOX CRO SPT CIP P T
N. gonorrhoeae (n = 21) S 21 (100) 21 (100) 20 (95.2) 12 (57.1) 0 0
I 0 0 1 (4.8) 3 (14.3) 0 0
R 0 0 0 6 (28.6) 21 (100) 21 (100)
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Hawasa, Ethiopia [6] 86.6 % in Gonder, Ethiopia [29] and 
77 % in Addis Ababa [30]. The variation in rate of penicil-
lin resistance N. gonorrhoeae isolates in the same country 
might be an indication of the overtime period rising in 
resistance trend of the bacteria to this drug.
Conclusions
In general, the prevalence of GC infection in the study 
area was relatively high as compared to findings docu-
mented in other regions of the country. Some of the risky 
cultural practices, substance use and sexual risk behav-
iors of the individuals showed an association in acquiring 
the infection. Therefore, behavioral and sexuality educa-
tion is required for those sexually active populations in 
that locality as some of the risk factors indicate knowl-
edge gap.
The absence of resistant N. gonorrhoeae isolates to 
ceftriaxone and cefoxitin in our study makes these anti-
biotic excellent first-line treatment options. However, 
the alarming percentage of resistance against ciprofloxa-
cin could significantly challenge the current use of this 
antibiotic in the syndromic management package of GC 
infections. Therefore, laboratory based diagnosis and 
antimicrobial susceptibility test systems need to be in 
place.
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